Published in CMAJ on July 12, 2010
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Vitamin D: deficiency, sufficiency and toxicity. Nutrients (2013) 1.07
A step in the right direction. CMAJ (2010) 1.05
Vitamin D status of refugees arriving in Canada: findings from the Calgary Refugee Health Program. Can Fam Physician (2013) 0.91
Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines. Can J Hosp Pharm (2012) 0.85
Vitamin D metabolism, functions and needs: from science to health claims. Eur J Nutr (2012) 0.81
Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency. Acta Pharmacol Sin (2012) 0.80
Bone health and associated metabolic complications in neuromuscular diseases. Phys Med Rehabil Clin N Am (2012) 0.80
The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am J Clin Nutr (2016) 0.79
Associations of vitamin D deficiency with postoperative gait and mortality among patients with fractures of the proximal femur. Rev Bras Ortop (2015) 0.78
The relationship between serum 25(OH)D and bone density and microarchitecture as measured by HR-pQCT. Osteoporos Int (2015) 0.78
Osteoporosis prescribing in long-term care: impact of a provincial knowledge translation strategy. Can J Aging (2015) 0.77
Chest pain and costochondritis associated with vitamin d deficiency: a report of two cases. Case Rep Med (2012) 0.76
Cholecalciferol and Cancer: Is It a Big D3-eal? J Adv Pract Oncol (2012) 0.75
Preventing fractures in postmenopausal women: how to assess risk. CMAJ (2011) 0.75
Vitamin D Deficiency Treatment Patterns in Academic Urban Medical Center. Am J Pharm Benefits (2014) 0.75
Vitamin D for mental health and cognition. CMAJ (2010) 0.75
Characterizing the assessment and management of vitamin d levels in patients with osteoporosis in clinical practice: a chart review initiative. J Osteoporos (2015) 0.75
Should I prescribe sunlight instead of vitamin D? CMAJ (2010) 0.75
Vitamin D deficiency adversely affects early post-operative functional outcomes after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc (2016) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med (1992) 9.86
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr (2004) 8.48
Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA (2006) 7.09
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med (1997) 6.88
Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab (2004) 6.41
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr (2005) 6.32
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst (2007) 4.89
Risk assessment for vitamin D. Am J Clin Nutr (2007) 4.34
Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr (2004) 3.76
Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab (2004) 3.71
Vitamin D and diabetes. Diabetologia (2005) 3.58
Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med (2004) 3.45
Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust (2005) 3.18
Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr (2008) 3.09
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int (2002) 2.82
Vitamin D insufficiency in a population of healthy western Canadians. CMAJ (2002) 2.73
Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol (2006) 2.39
Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc (2005) 2.38
Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr (2001) 2.22
A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc (2007) 2.12
Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol (2005) 2.01
Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res (2009) 1.66
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med (2006) 1.37
Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther (2006) 1.36
Vitamin D inadequacy among post-menopausal women: a systematic review. QJM (2005) 1.34
Are national vitamin D guidelines sufficient to maintain adequate blood levels in children? Can J Public Health (2005) 1.24
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res (2004) 1.22
Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1998) 1.22
A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer (2004) 1.09
Contemporary diagnosis and treatment of vitamin D-related disorders. J Bone Miner Res (2007) 0.94
The role of vitamin D in multiple sclerosis. Ann Pharmacother (2006) 0.88
A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur. N Z Med J (2000) 0.86
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med (2011) 3.84
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (2007) 3.51
Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev (2002) 3.46
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31
Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. JAMA (2013) 3.04
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Trends in hip fracture rates in Canada. JAMA (2009) 2.95
Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci (2004) 2.90
IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab (2012) 2.75
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Vitamin D insufficiency in a population of healthy western Canadians. CMAJ (2002) 2.73
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med (2007) 2.64
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med (2004) 2.48
Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab (2012) 2.41
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res (2010) 2.34
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res (2011) 2.24
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol (2012) 2.24
Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol (2008) 2.19
AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology (2003) 2.17
Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J (2005) 2.15
Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics (2005) 2.07
Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol (2008) 2.04
Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr (2004) 1.98
The 2002 Canadian bone densitometry recommendations: take-home messages. CMAJ (2002) 1.92
Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2009) 1.90
Vitamin D intake: a global perspective of current status. J Nutr (2005) 1.89
Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res (2014) 1.86
Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study. J Bone Miner Res (2011) 1.86
Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem (2009) 1.85
13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol (2007) 1.83
FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res (2012) 1.82
Low bone mineral density and fracture burden in postmenopausal women. CMAJ (2007) 1.81
The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know. J Am Diet Assoc (2011) 1.80
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80
Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med (2007) 1.63
Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev (2002) 1.62
Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5-14 y. J Nutr (2005) 1.61
Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology (2009) 1.59
Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm. Am J Gastroenterol (2008) 1.57
Relationship Among Body Fat Percentage, Body Mass Index, and All-Cause Mortality: A Cohort Study. Ann Intern Med (2016) 1.56
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
Meta-analysis of the quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis. Am J Clin Nutr (2008) 1.55
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55
Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev (2002) 1.53
Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol (2008) 1.53
Cost-effectiveness of hip protectors in institutional dwelling elderly. Osteoporos Int (2003) 1.51
A qualitative study of physicians' perceptions of three decision aids. Patient Educ Couns (2003) 1.49
Therapy insight: Osteoporosis in inflammatory bowel disease--advances and retreats. Nat Clin Pract Gastroenterol Hepatol (2005) 1.48
Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol (2003) 1.48
Calcium requirements for bone growth in Canadian boys and girls during adolescence. Br J Nutr (2009) 1.48
The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord (2002) 1.47
Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev (2003) 1.45
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.44
The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study. J Rheumatol (2013) 1.44
Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology (2004) 1.44
Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J Steroid Biochem Mol Biol (2010) 1.42
Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality. Nutr J (2011) 1.41
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial. J Clin Endocrinol Metab (2012) 1.38
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res (2010) 1.37
Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther (2006) 1.36
Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ (2008) 1.35
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.34
Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol (2008) 1.33
Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ (2008) 1.33
Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J (2007) 1.32
Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int (2005) 1.31
Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med (2005) 1.31
FRAX(®) with and without bone mineral density. Calcif Tissue Int (2011) 1.29
Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab (2014) 1.29
Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res (2007) 1.28
Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord (2005) 1.27
Canadian Aboriginal women have a higher prevalence of vitamin D deficiency than non-Aboriginal women despite similar dietary vitamin D intakes. J Nutr (2007) 1.27
Understanding and overcoming the barriers of implementing patient decision aids in clinical practice. J Eval Clin Pract (2006) 1.27
Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev (2002) 1.22
10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med (2008) 1.20
Meta-analysis of the effect of the acid-ash hypothesis of osteoporosis on calcium balance. J Bone Miner Res (2009) 1.19
Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19
Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab (2003) 1.19
Physicians' intentions and use of three patient decision aids. BMC Med Inform Decis Mak (2007) 1.19
Identifying wrist fracture patients with high accuracy by automatic categorization of X-ray reports. J Am Med Inform Assoc (2006) 1.19